Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pamela Ann Connealy currently holds 21,277 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pamela Ann Connealy has been a net buyer of PYXS stock. They have purchased $55.6K and sold $0 worth of shares.
Pamela Ann Connealy's most recent insider trade was on Jun 23, 2026, when they sold 21,277 shares at $0.00 per share.
Pamela Ann Connealy serves as Executive at Pyxis Oncology, Inc. (PYXS). They have executed 14 insider transactions totaling $55.6K over their tenure at the company.
Pamela Ann Connealy holds the position of Executive at Pyxis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Pamela Ann Connealy has shown a buying trading pattern, with $55.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Pamela Ann Connealy was on Nov 29, 2023, when they sold $51.7K worth of PYXS shares. This transaction involved 36,949 shares at $1.40 per share.
Pamela Ann Connealy currently owns 21,277 shares of Pyxis Oncology, Inc. (PYXS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pamela Ann Connealy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pamela Ann Connealy has 14 Form 4 filings on record as an insider at Pyxis Oncology, Inc..
Set alerts for Pamela Ann Connealy and 40,000+ other insiders.